Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice

Table 1

Serum lipid profile in two groups after 8-week treatment.

Groups (𝑛=15)	TC (mg/dL)	TG (mg/dL)	HDL-C (mg/dL)
Vehicle	1178.7 ± 123	463.6 ± 33	18.5 ± 2.1
Salidroside	524.3 ± 65***	237.5 ± 17***	20.7 ± 1.6**

TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein.
*** P < 0.001 **P < 0.01 versus vehicle group.